Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

628.27 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
2 Buffett Stocks to Buy More Of In October
Buffett doesn't flee bear markets. And neither should we. 
Via The Motley Fool
Warren Buffett's Buying This Passive Income Stock: Should You?
McKesson delivered share price gains and passive income so far this year. 
Via The Motley Fool
'Right Now I Don't Want To Back Away From It,' Jim Cramer Says About This Stock Down Only 8% This Year
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t want to back away from Iron Mountain Incorporated (NYSE: IRM) right now. "We may have to do new work on Iron Mountain to see if it’s as... 
Via Benzinga
5 Solid Dividend Growth Stocks For Q4
Five dividend growth stocks that could be compelling picks amid market volatility. 
Via Talk Markets
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
Vertex and LNG play Cheniere Energy are setting up bullishly. 
Via Investor's Business Daily
Warren Buffett's Buying This Passive Income Stock
You should have this blue chip healthcare stock on your radar. 
Via The Motley Fool
McKesson Buys Rx Savings Solutions For $875M
Via Benzinga
Where McKesson Stands With Analysts
Analysts have provided the following ratings for McKesson (NYSE:MCK) within the last quarter: 
Via Benzinga
Is This Buffett-Backed Blue Chip Stock a Buy?
Berkshire Hathaway increased its stake in this healthcare stock by 9.5% in the second quarter. 
Via The Motley Fool
Cardinal Health Clears Base, But Can It Maintain Uptrend?
Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday. 
Via MarketBeat
Why Ticker Symbols Mean Very Little: Three Tech Giants Versus An Obscure Stock
The S&P 500 continues to do battle with the weekly 200 simple moving average, a critical level that will determine if we see a repeat of 2000 and 2008 or a revival of a bull market.  
Via Benzinga
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term. 
Via InvestorPlace
3 Stocks to Add to Your Portfolio in the Market Downturn
All three companies have easily surpassed the S&P 500 average this year. 
Via The Motley Fool
Where McKesson Stands With Analysts
Analysts have provided the following ratings for McKesson (NYSE:MCK) within the last quarter: 
Via Benzinga
ZoomInfo Technologies, McKesson And This Restaurant Stock Insiders Are Selling
US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
From McKesson Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
3 Medical Stocks Displaying Remarkable Relative Strength In 2022
3 medical stocks that displayed a substantial amount of relative strength year-to-date. 
Via Talk Markets
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
Eli Lilly leads medical stocks setting up and showing relative strength. 
Via Investor's Business Daily
Amazon, Target And 3 Other Stocks Insiders Are Selling
U.S. crude oil futures traded lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
McKesson Signs Agreement to Acquire Rx Savings Solutions
From McKesson Corporation
Via Business Wire
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
From McKesson Corporation
Via Business Wire
Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of
Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved... 
Via Benzinga
5 Dividend Growth Stocks To Beat September Slump
Here are five dividend growth stocks that could be solid picks to beat the September slump. 
Via Talk Markets
Morgan Stanley Maintains Overweight Rating for McKesson: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of McKesson (NYSE:MCK) and raise its price target from $370.00 to $403.00. Shares of McKesson are trading down 0.39% over the last 24 hours,... 
Via Benzinga
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading. 
Via Benzinga
Best U.S. Performing Stocks
5 stocks that outperformed the US market in 2022 as of mid-June. 
Via Talk Markets
PYPL Up 51% Since July. Time To Buy?
PayPal Holdings Inc (NASDAQ: PYPL) has taken a real beating over the last 12 months, with the price dropping 80% between the high of July 2021 and the low of June 2022.  
Via Benzinga
3 Stock Winners and Losers of Biden’s Inflation Reduction Act
The House of Representatives passed the Inflation Reduction Act on Aug. 12. Here are stock winners and losers from the bill. 
Via InvestorPlace
Apple Up 25% Since June: Is It Time to Buy?
The challenge for many is knowing how to filter for the best stocks from the thousands available. The trap? Buying into brand names thinking that the company is a sure bet.  The correct approach is... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.